Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Pharmacokinetics, pharmacodynamics and safety of i.v. RGD-891 studied in healthy volunteers

Oct. 24, 2000

Novel compounds identified at Merck as factor Xa inhibitors

Oct. 19, 2000

International patent coverage obtained for new thrombin inhibitors from Boehringer Ingelheim

Oct. 10, 2000

IND filed by Endovasc for Liprostin

Oct. 5, 2000

BLA supplement filed for alteplase

Oct. 4, 2000

New factor Xa inhibitors with therapeutic and diagnostic uses

Sep. 27, 2000

Lactam factor Xa inhibitors designed by BMS research groups

Sep. 26, 2000

Factor Xa inhibitors synthesized and tested at AstraZeneca

Sep. 22, 2000

Time to ambulation following angioplasty reduced on Neutralase

Sep. 21, 2000

Promising data reported from phase II trial of injectable anticoagulant

Sep. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...